Navigation Links
Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
Date:7/1/2009

Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no. O-005
  • Behr B, et al Corifollitropin alfa versus recombinant FSH treatment in controlled ovarian stimulation: equal efficacy in terms of oocyte and embryo quality. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no O-003
  • Doody K et al, Puregon reference-'Success rates of a fixed rFSH/GnRH antagonist protocol are not affected by enodgenous LH levels. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-255
  • Ledger W et al, Two doses of corifollitropin alfa allow for similar exposure and ovarian response in patients weighing less than or equal to 60 kg and > 60 kg. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-282
  • Hillensjo T et al, Corifollitropin alfa versus recombinant FSH in a GnRH antagonist protocol for controlled ovarian stimulation in women weighing 60 kg or less. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on June 29, 2009. Abstract no. O-004
  • Fatemi HM et al, The first pilot study with corifollitropin alfa in a long GnRH agonist protocol indicates the development of a large cohort of follicles during the first week of ovarian stimulation. Oral presentation at 25th European Society of Human Reproduction and Embryology (ESHRE) on July 1, 2009. Abstract no. O-283
  • Frequently Asked Questions About Infertility. American Society for Reproductive Medicine Web site. http://www.asrm.org/Patients/faqs.html
    '/>"/>

    • SOURCE Schering-Plough
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
    2. Schering-Plough Announces Pricing of Senior Notes Offering
    3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
    4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
    5. Schering-Plough Completes Acquisition of Organon BioSciences
    6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
    7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
    8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
    9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
    10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
    11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/23/2009)...l. You can think of it as origami very high-tech...nois have developed a technique for fabricating th...ures from thin films by coupling photolithography ...eractions. , The films, only a few microns thick,... with thicker pieces of the same material. , "Thi...
    (Date:11/23/2009)...AUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSciences...velopmentcompanythatidentifiesandadvancesadiversep...stagesofdevelopment,todayreportedthatCytopia(ASX:C...ngCYT387,apotent,orally-administeredJAK1/JAK2inhib...er,Minnesota.AproposaltomergeCytopiaintoYMhasbeenp...
    (Date:11/23/2009)...,BC,Nov.23/PRNewswire/-InimexPharmaceuticals,Inc.a...DasitsPresidentandCEO. ,, Abramsbringsmorethan2...mex.Heisaco-inventorofthenuclearmedicineimagingage...hey,plcwherehewasManager,BiomedicalResearchWorldwi...ley,BCandwasPresidentandCEOfrom1996to2006.AnorMEDd...
    (Date:11/20/2009)... , , , , , , , ... AUDIO: , A team of scientists from Washi...rizona, Cold Spring Harbor Laboratory and Iowa Sta...orn. The... , , Click here for mo... , , , , , , , ...
    Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Inimex Announces Appointment of New CEO 2Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
    ... CITY, April 16 ARUP Laboratories, a national,cli...and a leader in,innovative laboratory research and...der Carl R. Kjeldsberg, MD, will retire as chief e...eldsberg has held the position,since 1993 and will...n of,the Board., Effective, July 1, 2009, Edward ...
    ...Also Celebrates Opening of Hollings Expanded Build...ersity of,South Carolina,s Hollings Cancer Center ...ling Garden. The healing garden, designed by Rober...Edwin S. Pearlstine, Jr., in memory,of his wife of...cancer in,1997., "Edwin and Barbara Pearlstine wi...
    ...nd CLAREMONT, Calif., Apr 16 /Xinhua-PRNewswire-Fi...on (OTC Bulletin Board: KWBT), ("the,Company" and ...Li, General,Manager of Huaxing Animal Medicine Co....njun Luo, Kiwa CFO, at Kiwa Beijing headquarters. ...isal of the assets, both parties,signed a memorand...
    Other Biology Technology:ARUP Laboratories CEO and Co-Founder Announces Retirement 2MUSC's Hollings Cancer Center Dedicates Edwin and Barbara Pearlstine Healing Garden Endowed with $1 Million Gift from Edwin S. Pearlstine, Jr. 2Kiwa and Huaxing Set Up Preparatory Team for New Joint-venture Company 2
    (Date:11/22/2009)...scientists have succeeded in producing the polymer...g, rather than through the use of fossil fuel base...ay now allow for the production of environmentally... the journal Biotechnology and Bioengineering to...s are molecules found in everyday life in the form...
    (Date:11/22/2009)... can increase the likelihood of immune complicatio...national team of researchers reports in the Novemb...hen the gene, called UGT2B17, is missing from the ...nsplants have a significantly greater risk of a se...se, in which immune cells from the donor attack ti...
    (Date:11/22/2009)... Agios Pharmaceuticals today announced that its s...at the mutated IDH1 gene has a novel enzyme activi...ene. This breakthrough discovery shows that the mu...yglutarate (2HG), which may contribute to the form...st common type of brain cancers. This discovery ap...
    Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4Many Young Adults Uninformed About Vaccines 52443 1Many Young Adults Uninformed About Vaccines 52443 2Many Young Adults Uninformed About Vaccines 52443 3SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 1SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 2SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 3SedationFacts org Presents Content on Policies and Conditions Regarding Alternative Methods for the Administration of Propofol 52439 4Counterfeit antimalarial drug discovered in Ghana 52436 1Counterfeit antimalarial drug discovered in Ghana 52436 2Counterfeit antimalarial drug discovered in Ghana 52436 3
    ...scientists replace pricey solvents with cheap proc...rge-scale manufacture of fluorescent quantum dots,...w method of replacing the pricey solvents used in ...ommonplace at industrial chemical plants. , Rice,s...the Center for Biological and Environmental Nanote...
    ...r computation of haplotypes provides insight into ...encing of an individual,s DNA yields a map of gene...underpinning of human disease. The current techno...individual,s two chromosomes. Yet many scientists...een individuals, DNA at the level of each chromoso...
    ...h quick to caution about the many things that coul...e to contain a Southeast Asian outbreak of avian i...roduction of a vaccine. , Using a computer model t...population, the scientists have shown how a combin...tion of antivirals, quarantine and prevaccination ...
    Other Biology News:Method slashes quantum dot costs by 80 percent 2Method slashes quantum dot costs by 80 percent 3U-M scientists say fused genes trigger the development of prostate cancer 2U-M scientists say fused genes trigger the development of prostate cancer 3U-M scientists say fused genes trigger the development of prostate cancer 4Preventing a pandemic: Study suggests strategies for containing a flu outbreak 2Preventing a pandemic: Study suggests strategies for containing a flu outbreak 3
    Mouse Anti-SOCS3 Monoclonal Antibody, Unconjugated, Clone SOC-25 from BioLegend
    Mouse Anti-Synapsin I Monoclonal Antibody, Unconjugated, Clone 223 from IMGENEX
    PBMC Cell Chip-IHC from 3H Biomedical AB
    UCB Monocyte Cell Chip-IHC from 3H Biomedical AB
    Biology Products: